Features September 2012 Issue

Novartis Brand Canine Drug Shortages Continue

Plant shutdowns make it hard to find certain canine veterinary medications.

Novartis Animal Health suspended production at its Lincoln, Nebraska, plant in December 2011 following a series of warnings from the U.S. Food and Drug Administration (FDA) regarding manufacturing and quality control violations. At that time, the only veterinary drugs affected were the heartworm and flea products Interceptor, Program, and Sentinel. Novartis said it hoped to return to full production in January. Instead, further problems were discovered when Novartis warned veterinarians about possible tablet mix-ups in bottles of Clomicalm, used to treat separation anxiety. On January 5th, Novartis sent a letter to veterinarians informing them that it was suspending production and shipments of Clomicalm and Milbemite (used to treat ear mites) in addition to the products listed above.

To continue reading this article you must be a paid subscriber.

Subscribe today and save 72%. It's like getting 8 months FREE!

Here's what you'll get:

  • Immediate access to this article.
  • Access to more than 1,000 Whole Dog Journal articles like this.
  • Each, new monthly issue delivered to you.
  • Recommendations of the best dog food for your dog.
  • The most effective positive dog training methods.
  • Help understanding when your dog is bored, anxious, tired, or hungry. You won't believe some of the signs!
  • The healthiest and most effective homeopathic and mainstream remedies, diets, and medicines.

Your satisfaction to The Whole Dog Journal is guaranteed. Subscribe today to see why hundreds of thousands of dog owners trust us as the #1 source of canine information.

 

Subscriber Log In

Forgot your password? Click Here.
Already subscribed but haven't registered for all the benefits of the website? Click here.